198 related articles for article (PubMed ID: 17438657)
1. [Gene polymorphism and gene expression in schizophrenia].
Mátyás T
Psychiatr Hung; 2006; 21(6):404-12. PubMed ID: 17438657
[TBL] [Abstract][Full Text] [Related]
2. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia.
Nicodemus KK; Kolachana BS; Vakkalanka R; Straub RE; Giegling I; Egan MF; Rujescu D; Weinberger DR
Hum Genet; 2007 Feb; 120(6):889-906. PubMed ID: 17006672
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.
Harrison PJ; Weinberger DR
Mol Psychiatry; 2005 Jan; 10(1):40-68; image 5. PubMed ID: 15263907
[TBL] [Abstract][Full Text] [Related]
4. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity.
Lipska BK; Mitkus S; Caruso M; Hyde TM; Chen J; Vakkalanka R; Straub RE; Weinberger DR; Kleinman JE
Hum Mol Genet; 2006 Sep; 15(18):2804-12. PubMed ID: 16905560
[TBL] [Abstract][Full Text] [Related]
5. [In search of susceptibility genes for schizophrenia].
Schosser A; Aschauer HN
Wien Klin Wochenschr; 2004 Dec; 116(24):827-33. PubMed ID: 15690966
[TBL] [Abstract][Full Text] [Related]
6. Translational and developmental perspective on N-methyl-D-aspartate synaptic deficits in schizophrenia.
MacDonald AW; Chafee MV
Dev Psychopathol; 2006; 18(3):853-76. PubMed ID: 17152404
[TBL] [Abstract][Full Text] [Related]
7. The genes for schizophrenia: finally a breakthrough?
Shirts BH; Nimgaonkar V
Curr Psychiatry Rep; 2004 Aug; 6(4):303-12. PubMed ID: 15260947
[TBL] [Abstract][Full Text] [Related]
8. Schizophrenia: an update and review.
Austin J
J Genet Couns; 2005 Oct; 14(5):329-40. PubMed ID: 16195940
[TBL] [Abstract][Full Text] [Related]
9. Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes.
Sacchetti E; Scassellati C; Minelli A; Valsecchi P; Bonvicini C; Pasqualetti P; Galluzzo A; Pioli R; Gennarelli M
BMC Med Genet; 2013 Mar; 14():33. PubMed ID: 23497497
[TBL] [Abstract][Full Text] [Related]
10. Risk Genes in Schizophrenia and Their Importance in Choosing the Appropriate Antipsychotic Treatment.
Werner FM; Coveñas R
Curr Pharm Des; 2021 Oct; 27(30):3281-3292. PubMed ID: 33588721
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism and neuroanatomical changes in schizophrenia.
Năstase MG; Vlaicu I; Trifu SC
Rom J Morphol Embryol; 2022; 63(2):307-322. PubMed ID: 36374137
[TBL] [Abstract][Full Text] [Related]
12. Lack of change in markers of presynaptic terminal abundance alongside subtle reductions in markers of presynaptic terminal plasticity in prefrontal cortex of schizophrenia patients.
Fung SJ; Sivagnanasundaram S; Weickert CS
Biol Psychiatry; 2011 Jan; 69(1):71-9. PubMed ID: 21145444
[TBL] [Abstract][Full Text] [Related]
13. [Advances in molecular genetics of schizophrenia].
Chen WY; He L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):401-7. PubMed ID: 16038285
[TBL] [Abstract][Full Text] [Related]
14. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia.
Bakker SC; Hoogendoorn ML; Hendriks J; Verzijlbergen K; Caron S; Verduijn W; Selten JP; Pearson PL; Kahn RS; Sinke RJ
Genes Brain Behav; 2007 Mar; 6(2):113-9. PubMed ID: 17410640
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the genetics of schizophrenia.
O'Donovan MC; Williams NM; Owen MJ
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R125-33. PubMed ID: 12952866
[TBL] [Abstract][Full Text] [Related]
16. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology.
Craddock N; O'Donovan MC; Owen MJ
Schizophr Bull; 2006 Jan; 32(1):9-16. PubMed ID: 16319375
[TBL] [Abstract][Full Text] [Related]
17. Linkage and association studies of schizophrenia.
McGuffin P; Tandon K; Corsico A
Curr Psychiatry Rep; 2003 Jun; 5(2):121-7. PubMed ID: 12685991
[TBL] [Abstract][Full Text] [Related]
18. Dual constraints on synapse formation and regression in schizophrenia: neuregulin, neuroligin, dysbindin, DISC1, MuSK and agrin.
Bennett A O MR
Aust N Z J Psychiatry; 2008 Aug; 42(8):662-77. PubMed ID: 18622774
[TBL] [Abstract][Full Text] [Related]
19. Synaptic dysfunction in schizophrenia.
Yin DM; Chen YJ; Sathyamurthy A; Xiong WC; Mei L
Adv Exp Med Biol; 2012; 970():493-516. PubMed ID: 22351070
[TBL] [Abstract][Full Text] [Related]
20. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.
Numakawa T; Yagasaki Y; Ishimoto T; Okada T; Suzuki T; Iwata N; Ozaki N; Taguchi T; Tatsumi M; Kamijima K; Straub RE; Weinberger DR; Kunugi H; Hashimoto R
Hum Mol Genet; 2004 Nov; 13(21):2699-708. PubMed ID: 15345706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
